Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Ischemic Heart Disease

  Free Subscription


Articles published in Eur Heart J

Retrieve available abstracts of 97 articles:
HTML format
Text format



Single Articles


    February 2019
  1. WITASSEK F, Radovanovic D, Erne P, Puhan M, et al
    Mortality with antidepressants after acute MI: Antidepressant use after acute myocardial infarction (MI) is associated with an increased mortality 1 year after discharge from Swiss hospitals.
    Eur Heart J. 2019;40:410.
    PubMed     Text format    


    January 2019
  2. CHEN S, Stone GW
    Circadian influences, time of hospitalization, and prognosis in acute myocardial infarction.
    Eur Heart J. 2019 Jan 30. pii: 5304404. doi: 10.1093.
    PubMed     Text format    


  3. WU J, Hall M, Dondo TB, Wilkinson C, et al
    Association between time of hospitalization with acute myocardial infarction and in-hospital mortality.
    Eur Heart J. 2019 Jan 29. pii: 5301310. doi: 10.1093.
    PubMed     Text format     Abstract available


  4. VACCARINO V, Badimon L, Bremner JD, Cenko E, et al
    Depression and coronary heart disease: 2018 ESC position paper of the working group of coronary pathophysiology and microcirculation developed under the auspices of the ESC Committee for Practice Guidelines.
    Eur Heart J. 2019 Jan 28. pii: 5303703. doi: 10.1093.
    PubMed     Text format    


  5. THYGESEN K
    'Ten Commandments' for the Fourth Universal Definition of Myocardial Infarction 2018.
    Eur Heart J. 2019;40:226.
    PubMed     Text format    


    December 2018
  6. RESOR CD, Bhatt DL
    Bioresorbable vascular scaffolds in acute myocardial infarction: non-inferior or not enough data?
    Eur Heart J. 2018 Dec 18. pii: 5251899. doi: 10.1093.
    PubMed     Text format    


  7. BYRNE RA, Alfonso F, Schneider S, Maeng M, et al
    Prospective, randomized trial of bioresorbable scaffolds vs. everolimus-eluting stents in patients undergoing coronary stenting for myocardial infarction: the Intracoronary Scaffold Assessment a Randomized evaluation of Absorb in Myocardial Infarction
    Eur Heart J. 2018 Dec 5. pii: 5231946. doi: 10.1093.
    PubMed     Text format     Abstract available


    November 2018
  8. SHARMA S, Malhotra A
    Exercise testing and coronary disease: pushing fitness to higher peaks.
    Eur Heart J. 2018 Nov 29. pii: 5193507. doi: 10.1093.
    PubMed     Text format    


  9. LETNES JM, Dalen H, Vesterbekkmo EK, Wisloff U, et al
    Peak oxygen uptake and incident coronary heart disease in a healthy population: the HUNT Fitness Study.
    Eur Heart J. 2018 Nov 29. pii: 5193503. doi: 10.1093.
    PubMed     Text format     Abstract available


  10. XIN Y, Chen X, Hu W
    Oxygen therapy in ST-elevation myocardial infarction.
    Eur Heart J. 2018 Nov 28. pii: 5212709. doi: 10.1093.
    PubMed     Text format    


  11. POLIMENI A, Spaccarotella C, Mongiardo A, Indolfi C, et al
    Myocardial infarction after dog bite.
    Eur Heart J. 2018 Nov 28. pii: 5212711. doi: 10.1093.
    PubMed     Text format    


  12. BERGMARK BA, Faxon DP
    Transient ST-segment myocardial infarction: a new category of high risk acute coronary syndrome?
    Eur Heart J. 2018 Nov 15. pii: 5184544. doi: 10.1093.
    PubMed     Text format    


  13. THYGESEN K
    What's new in the Fourth Universal Definition of Myocardial infarction?
    Eur Heart J. 2018;39:3757-3758.
    PubMed     Text format    


  14. ELNABAWI YA, Dey AK, Mehta NN
    Emerging Applications of Coronary CT Angiography in Coronary Heart Disease: Getting Better with Time.
    Eur Heart J. 2018;39:3682-3684.
    PubMed     Text format    


    October 2018
  15. FARAG M, Spinthakis N, Gue YX, Srinivasan M, et al
    Impaired endogenous fibrinolysis in ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention is a predictor of recurrent cardiovascular events: the RISK PPCI study.
    Eur Heart J. 2018 Oct 30. pii: 5149701. doi: 10.1093.
    PubMed     Text format     Abstract available


  16. LEMKES JS, Janssens GN, van der Hoeven NW, van de Ven PM, et al
    Timing of revascularization in patients with transient ST-segment elevation myocardial infarction: a randomized clinical trial.
    Eur Heart J. 2018 Oct 26. pii: 5145843. doi: 10.1093.
    PubMed     Text format     Abstract available


  17. HERITIER H, Vienneau D, Foraster M, Eze IC, et al
    A systematic analysis of mutual effects of transportation noise and air pollution exposure on myocardial infarction mortality: a nationwide cohort study in Switzerland.
    Eur Heart J. 2018 Oct 24. pii: 5144026. doi: 10.1093.
    PubMed     Text format     Abstract available


  18. WALLENTIN L
    Different perspectives on outcomes in patients with non-ST-elevation myocardial infarction when observed in clinical trials and in real life.
    Eur Heart J. 2018 Oct 17. pii: 5137113. doi: 10.1093.
    PubMed     Text format    


    September 2018
  19. SZUMMER K, Wallentin L, Lindhagen L, Alfredsson J, et al
    Relations between implementation of new treatments and improved outcomes in patients with non-ST-elevation myocardial infarction during the last 20 years: experiences from SWEDEHEART registry 1995 to 2014.
    Eur Heart J. 2018 Sep 19. pii: 5103432. doi: 10.1093.
    PubMed     Text format     Abstract available


  20. HALL M, Bebb OJ, Dondo TB, Yan AT, et al
    Guideline-indicated treatments and diagnostics, GRACE risk score, and survival for non-ST elevation myocardial infarction.
    Eur Heart J. 2018 Sep 7. pii: 5092654. doi: 10.1093.
    PubMed     Text format     Abstract available


  21. MONTONE RA, Niccoli G, Lanza GA, Crea F, et al
    Reconsidering aetiologies of type 2 myocardial infarction: when a classification is a simplistic approach for a complex reality.
    Eur Heart J. 2018 Sep 6. pii: 5091846. doi: 10.1093.
    PubMed     Text format    


  22. NESTELBERGER T, Boeddinghaus J, Mueller C
    Type 2 myocardial infarction.
    Eur Heart J. 2018 Sep 6. pii: 5091844. doi: 10.1093.
    PubMed     Text format    


    August 2018
  23. BOEDDINGHAUS J, Nestelberger T, Twerenbold R, Neumann JT, et al
    Impact of age on the performance of the ESC 0/1h-algorithms for early diagnosis of myocardial infarction.
    Eur Heart J. 2018 Aug 29. pii: 5086724. doi: 10.1093.
    PubMed     Text format     Abstract available


  24. THYGESEN K, Alpert JS, Jaffe AS, Chaitman BR, et al
    Fourth universal definition of myocardial infarction (2018).
    Eur Heart J. 2018 Aug 25. pii: 5079081. doi: 10.1093.
    PubMed     Text format    


  25. SHIMONO H, Kajiya T, Atsuchi Y, Atsuchi N, et al
    Giant left ventricular pseudo-aneurysm after posterior myocardial infarction.
    Eur Heart J. 2018 Aug 21. pii: 5077320. doi: 10.1093.
    PubMed     Text format    


    July 2018
  26. LUSCHER TF
    Performance of modern stents in stable and acute coronary disease.
    Eur Heart J. 2018;39:2435-2438.
    PubMed     Text format    


    June 2018
  27. SAITO S, Krucoff MW, Nakamura S, Mehran R, et al
    Japan-United States of America Harmonized Assessment by Randomized Multicentre Study of OrbusNEich's Combo StEnt (Japan-USA HARMONEE) study: primary results of the pivotal registration study of combined endothelial progenitor cell capture and drug-elu
    Eur Heart J. 2018 Jun 21. pii: 5042208. doi: 10.1093.
    PubMed     Text format     Abstract available


  28. HOFMANN R, Witt N, Lagerqvist B, Jernberg T, et al
    Oxygen therapy in ST-elevation myocardial infarction.
    Eur Heart J. 2018 Jun 14. pii: 5037999. doi: 10.1093.
    PubMed     Text format     Abstract available


    May 2018
  29. MONTONE RA, Niccoli G, Lanza GA, Crea F, et al
    Personalized treatment of myocardial infarction and non-obstructive coronary arteries: an unmet need in a high-risk population.
    Eur Heart J. 2018 May 29. pii: 5020746. doi: 10.1093.
    PubMed     Text format    


  30. IBANEZ B, Halvorsen S, Roffi M, Bueno H, et al
    Integrating the results of the CULPRIT-SHOCK trial in the 2017 ESC ST-elevation myocardial infarction guidelines: viewpoint of the task force.
    Eur Heart J. 2018 May 29. pii: 5020748. doi: 10.1093.
    PubMed     Text format    


  31. JANSSENS SP, Bogaert J, Zalewski J, Toth A, et al
    Nitric oxide for inhalation in ST-elevation myocardial infarction (NOMI): a multicentre, double-blind, randomized controlled trial.
    Eur Heart J. 2018 May 24. pii: 5003325. doi: 10.1093.
    PubMed     Text format     Abstract available


    April 2018
  32. MAHMOUD KD, Jolly SS, James S, Dzavik V, et al
    Clinical impact of direct stenting and interaction with thrombus aspiration in patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention: Thrombectomy Trialists Collaboration.
    Eur Heart J. 2018 Apr 21. pii: 4975836. doi: 10.1093.
    PubMed     Text format     Abstract available


    March 2018
  33. AUFFRET V, Cottin Y, Leurent G, Gilard M, et al
    Predicting the development of in-hospital cardiogenic shock in patients with ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention: the ORBI risk score.
    Eur Heart J. 2018 Mar 15. pii: 4938779. doi: 10.1093.
    PubMed     Text format     Abstract available


  34. DAI J, Xing L, Jia H, Zhu Y, et al
    In vivo predictors of plaque erosion in patients with ST-segment elevation myocardial infarction: a clinical, angiographical, and intravascular optical coherence tomography study.
    Eur Heart J. 2018 Mar 13. pii: 4934156. doi: 10.1093.
    PubMed     Text format     Abstract available


    February 2018
  35. THYGESEN K, Jaffe AS
    The prognostic impact of periprocedural myocardial infarction and injury.
    Eur Heart J. 2018 Feb 26. pii: 4911112. doi: 10.1093.
    PubMed     Text format    


  36. QAYYUM F, Lauridsen BK, Frikke-Schmidt R, Kofoed KF, et al
    Genetic variants in CYP7A1 and risk of myocardial infarction and symptomatic gallstone disease.
    Eur Heart J. 2018 Feb 23. pii: 4907930. doi: 10.1093.
    PubMed     Text format     Abstract available



  37. euro6.5 million award to study impact of ECMO on myocardial infarction patients.
    Eur Heart J. 2018;39:649.
    PubMed     Text format    


  38. WIJNS W, Naber CK
    Reperfusion delay in patients with high-risk ST-segment elevation myocardial infarction: every minute counts, much more than suspected.
    Eur Heart J. 2018 Feb 14. pii: 4855285. doi: 10.1093.
    PubMed     Text format    


  39. SCHOLZ KH, Maier SKG, Maier LS, Lengenfelder B, et al
    Impact of treatment delay on mortality in ST-segment elevation myocardial infarction (STEMI) patients presenting with and without haemodynamic instability: results from the German prospective, multicentre FITT-STEMI trial.
    Eur Heart J. 2018 Feb 14. pii: 4855284. doi: 10.1093.
    PubMed     Text format     Abstract available


    January 2018
  40. ZEITOUNI M, Silvain J, Guedeney P, Kerneis M, et al
    Periprocedural myocardial infarction and injury in elective coronary stenting.
    Eur Heart J. 2018 Jan 20. pii: 4815728. doi: 10.1093.
    PubMed     Text format     Abstract available


  41. LUSCHER TF
    ST-segment elevation myocardial infarction: the new ESC Guidelines.
    Eur Heart J. 2018;39:75-78.
    PubMed     Text format    


  42. KIM K, Park SM, Lee K
    Weight gain after smoking cessation does not modify its protective effect on myocardial infarction and stroke: evidence from a cohort study of men.
    Eur Heart J. 2018 Jan 6. pii: 4791953. doi: 10.1093.
    PubMed     Text format     Abstract available


    December 2017
  43. KOENIG T, Sedding DG, Wester HJ, Derlin T, et al
    Seeing the unseen: post-infarction inflammation in an isolated right ventricular myocardial infarction visualized by combined cardiac magnetic resonance imaging and chemokine receptor CXCR4-targeted molecular imaging.
    Eur Heart J. 2017 Dec 27. pii: 4780241. doi: 10.1093.
    PubMed     Text format    


  44. MONTONE RA, Niccoli G, Fracassi F, Russo M, et al
    Patients with acute myocardial infarction and non-obstructive coronary arteries: safety and prognostic relevance of invasive coronary provocative tests.
    Eur Heart J. 2017 Dec 8. pii: 4710061. doi: 10.1093.
    PubMed     Text format     Abstract available


    November 2017
  45. KUBO T, Shinke T, Okamura T, Hibi K, et al
    Optical frequency domain imaging vs. intravascular ultrasound in percutaneous coronary intervention (OPINION trial): one-year angiographic and clinical results.
    Eur Heart J. 2017;38:3139-3147.
    PubMed     Text format     Abstract available


    October 2017
  46. KIM MK, Han K, Kim HS, Park YM, et al
    Cholesterol variability and the risk of mortality, myocardial infarction, and stroke: a nationwide population-based study.
    Eur Heart J. 2017 Oct 21. doi: 10.1093.
    PubMed     Text format     Abstract available


  47. THYGESEN K, Jaffe AS
    Detecting myocardial infarction type 2: targetting the right patients.
    Eur Heart J. 2017 Oct 5. doi: 10.1093.
    PubMed     Text format    


  48. MANIWA N, Fujino M, Nakai M, Nishimura K, et al
    Anticoagulation combined with antiplatelet therapy in patients with left ventricular thrombus after first acute myocardial infarction.
    Eur Heart J. 2017 Oct 3. doi: 10.1093.
    PubMed     Text format     Abstract available


    September 2017
  49. KIVIMAKI M, Nyberg ST, Batty GD, Kawachi I, et al
    Long working hours as a risk factor for atrial fibrillation: a multi-cohort study.
    Eur Heart J. 2017;38:2621-2628.
    PubMed     Text format     Abstract available


    August 2017
  50. KOJIMA S, Michikawa T, Ueda K, Sakamoto T, et al
    Asian dust exposure triggers acute myocardial infarction.
    Eur Heart J. 2017 Aug 29. doi: 10.1093.
    PubMed     Text format     Abstract available


  51. SZUMMER K, Wallentin L, Lindhagen L, Alfredsson J, et al
    Improved outcomes in patients with ST-elevation myocardial infarction during the last 20 years are related to implementation of evidence-based treatments: experiences from the SWEDEHEART registry 1995-2014.
    Eur Heart J. 2017 Aug 29. doi: 10.1093.
    PubMed     Text format     Abstract available


  52. IBANEZ B, James S, Agewall S, Antunes MJ, et al
    2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European S
    Eur Heart J. 2017 Aug 26. doi: 10.1093.
    PubMed     Text format    


  53. ESCANED J, Collet C, Ryan N, Luigi De Maria G, et al
    Clinical outcomes of state-of-the-art percutaneous coronary revascularization in patients with de novo three vessel disease: 1-year results of the SYNTAX II study.
    Eur Heart J. 2017 Aug 26. doi: 10.1093.
    PubMed     Text format     Abstract available


  54. LASSALE C, Tzoulaki I, Moons KGM, Sweeting M, et al
    Separate and combined associations of obesity and metabolic health with coronary heart disease: a pan-European case-cohort analysis.
    Eur Heart J. 2017 Aug 14. doi: 10.1093.
    PubMed     Text format     Abstract available


  55. NEUMANN JT, Sorensen NA, Rubsamen N, Ojeda F, et al
    Discrimination of patients with type 2 myocardial infarction.
    Eur Heart J. 2017 Aug 13. doi: 10.1093.
    PubMed     Text format     Abstract available


  56. D'ASCENZO F, Iannaccone M, Saint-Hilary G, Bertaina M, et al
    Impact of design of coronary stents and length of dual antiplatelet therapies on ischaemic and bleeding events: a network meta-analysis of 64 randomized controlled trials and 102 735 patients.
    Eur Heart J. 2017 Aug 11. doi: 10.1093.
    PubMed     Text format     Abstract available


  57. KHAN AR, Golwala H, Tripathi A, Bin Abdulhak AA, et al
    Impact of total occlusion of culprit artery in acute non-ST elevation myocardial infarction: a systematic review and meta-analysis.
    Eur Heart J. 2017 Aug 7. doi: 10.1093.
    PubMed     Text format     Abstract available


    July 2017
  58. DE WAHA S, Patel MR, Granger CB, Ohman EM, et al
    Relationship between microvascular obstruction and adverse events following primary primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: an individual patient data pooled analysis from seven randomized trials.
    Eur Heart J. 2017 Jul 28. doi: 10.1093.
    PubMed     Text format     Abstract available


  59. VRANCKX P, Windecker S, Welsh RC, Valgimigli M, et al
    Thrombo-embolic prevention after transcatheter aortic valve implantation.
    Eur Heart J. 2017 Jul 25. doi: 10.1093.
    PubMed     Text format     Abstract available


  60. HOPEWELL JC, Malik R, Valdes-Marquez E, Worrall BB, et al
    Differential effects of PCSK9 variants on risk of coronary disease and ischaemic stroke.
    Eur Heart J. 2017 Jul 17. doi: 10.1093.
    PubMed     Text format     Abstract available


  61. POTHINENI NVK, Subramany S, Kuriakose K, Shirazi LF, et al
    Infections, atherosclerosis, and coronary heart disease.
    Eur Heart J. 2017 Jul 12. doi: 10.1093.
    PubMed     Text format     Abstract available


    May 2017
  62. ZITTERMANN A, Ernst JB, Prokop S, Fuchs U, et al
    Effect of vitamin D on all-cause mortality in heart failure (EVITA): a 3-year randomized clinical trial with 4000 IU vitamin D daily.
    Eur Heart J. 2017 May 12. doi: 10.1093.
    PubMed     Text format     Abstract available


    April 2017
  63. SINGH-MANOUX A, Fayosse A, Sabia S, Canonico M, et al
    Atrial fibrillation as a risk factor for cognitive decline and dementia.
    Eur Heart J. 2017 Apr 29. doi: 10.1093.
    PubMed     Text format     Abstract available


  64. VRANCKX P, Frigoli E, Rothenbuhler M, Tomassini F, et al
    Radial versus femoral access in patients with acute coronary syndromes with or without ST-segment elevation.
    Eur Heart J. 2017;38:1069-1080.
    PubMed     Text format     Abstract available


  65. GABET A, Danchin N, Juilliere Y, Olie V, et al
    Acute coronary syndrome in women: rising hospitalizations in middle-aged French women, 2004-14.
    Eur Heart J. 2017;38:1060-1065.
    PubMed     Text format     Abstract available


  66. PALMERINI T, Della Riva D, Benedetto U, Bacchi Reggiani L, et al
    Three, six, or twelve months of dual antiplatelet therapy after DES implantation in patients with or without acute coronary syndromes: an individual patient data pairwise and network meta-analysis of six randomized trials and 11 473 patients.
    Eur Heart J. 2017;38:1034-1043.
    PubMed     Text format     Abstract available


  67. GEBHARD C
    Women and acute coronary syndromes: still up to no good.
    Eur Heart J. 2017;38:1066-1068.
    PubMed     Text format    


  68. ONUMA Y, Serruys PW
    Freedom from long DAPT signals the demise of the bare-metal stent.
    Eur Heart J. 2017;38:970-973.
    PubMed     Text format    


  69. CARLSSON M
    The impacts on healthcare when coronary angiography as the reference method for diagnostic accuracy of coronary artery disease is replaced by fractional flow reserve!
    Eur Heart J. 2017;38:999-1001.
    PubMed     Text format    


    March 2017
  70. LI XS, Obeid S, Klingenberg R, Gencer B, et al
    Gut microbiota-dependent trimethylamine N-oxide in acute coronary syndromes: a prognostic marker for incident cardiovascular events beyond traditional risk factors.
    Eur Heart J. 2017;38:814-824.
    PubMed     Text format     Abstract available


  71. JIA H, Dai J, Hou J, Xing L, et al
    Effective anti-thrombotic therapy without stenting: intravascular optical coherence tomography-based management in plaque erosion (the EROSION study).
    Eur Heart J. 2017;38:792-800.
    PubMed     Text format     Abstract available


    February 2017
  72. LYALL DM, Celis-Morales CA, Anderson J, Gill JM, et al
    Associations between single and multiple cardiometabolic diseases and cognitive abilities in 474 129 UK Biobank participants.
    Eur Heart J. 2017;38:577-583.
    PubMed     Text format     Abstract available


  73. MORTENSEN MB, Nordestgaard BG, Afzal S, Falk E, et al
    ACC/AHA guidelines superior to ESC/EAS guidelines for primary prevention with statins in non-diabetic Europeans: the Copenhagen General Population Study.
    Eur Heart J. 2017;38:586-594.
    PubMed     Text format     Abstract available


  74. DEFILIPPIS AP, Young R, McEvoy JW, Michos ED, et al
    Risk score overestimation: the impact of individual cardiovascular risk factors and preventive therapies on the performance of the American Heart Association-American College of Cardiology-Atherosclerotic Cardiovascular Disease risk score in a modern
    Eur Heart J. 2017;38:598-608.
    PubMed     Text format     Abstract available


  75. SHUN-SHIN MJ, Zheng SL, Cole GD, Howard JP, et al
    Implantable cardioverter defibrillators for primary prevention of death in left ventricular dysfunction with and without ischaemic heart disease: a meta-analysis of 8567 patients in the 11 trials.
    Eur Heart J. 2017 Feb 21. doi: 10.1093.
    PubMed     Text format     Abstract available


  76. ODAKA Y, Takahashi J, Tsuburaya R, Nishimiya K, et al
    Plasma concentration of serotonin is a novel biomarker for coronary microvascular dysfunction in patients with suspected angina and unobstructive coronary arteries.
    Eur Heart J. 2017;38:489-496.
    PubMed     Text format     Abstract available


  77. KARAKAS M, Schulte C, Appelbaum S, Ojeda F, et al
    Circulating microRNAs strongly predict cardiovascular death in patients with coronary artery disease-results from the large AtheroGene study.
    Eur Heart J. 2017;38:516-523.
    PubMed     Text format     Abstract available


  78. MOTWANI M, Dey D, Berman DS, Germano G, et al
    Machine learning for prediction of all-cause mortality in patients with suspected coronary artery disease: a 5-year multicentre prospective registry analysis.
    Eur Heart J. 2017;38:500-507.
    PubMed     Text format     Abstract available


  79. PRIES AR, Reglin B
    Coronary microcirculatory pathophysiology: can we afford it to remain a black box?
    Eur Heart J. 2017;38:478-488.
    PubMed     Text format     Abstract available


  80. NIELSEN LH, Botker HE, Sorensen HT, Schmidt M, et al
    Prognostic assessment of stable coronary artery disease as determined by coronary computed tomography angiography: a Danish multicentre cohort study.
    Eur Heart J. 2017;38:413-421.
    PubMed     Text format     Abstract available


  81. VAN DER VALK FM, Kuijk C, Verweij SL, Stiekema LCA, et al
    Increased haematopoietic activity in patients with atherosclerosis.
    Eur Heart J. 2017;38:425-432.
    PubMed     Text format     Abstract available


  82. BOURANTAS CV, Jaffer FA, Gijsen FJ, van Soest G, et al
    Hybrid intravascular imaging: recent advances, technical considerations, and current applications in the study of plaque pathophysiology.
    Eur Heart J. 2017;38:400-412.
    PubMed     Text format     Abstract available


  83. LEIPSIC J, Blanke P
    Prognostic value of coronary CT angiography: lessons from the West Denmark Cardiac Registry.
    Eur Heart J. 2017;38:422-424.
    PubMed     Text format    


  84. CIMATO TR
    Persistent stem cell-driven inflammation in patients with prior MI and stroke.
    Eur Heart J. 2017;38:433-435.
    PubMed     Text format    


    December 2016
  85. BARTUNEK J, Terzic A, Davison BA, Filippatos GS, et al
    Cardiopoietic cell therapy for advanced ischemic heart failure: results at 39 weeks of the prospective, randomized, double blind, sham-controlled CHART-1 clinical trial.
    Eur Heart J. 2016 Dec 23. pii: ehw543. doi: 10.1093.
    PubMed     Text format     Abstract available


  86. PELLICANO M, De Bruyne B, Toth GG, Casselman F, et al
    Fractional flow reserve to guide and to assess coronary artery bypass grafting.
    Eur Heart J. 2016 Dec 23. pii: ehw505. doi: 10.1093.
    PubMed     Text format     Abstract available


    November 2016
  87. RYAN N, Escaned J
    Myocardial bridge as a cause of persistent post percutaneous coronary intervention angina identified with exercise intracoronary physiology.
    Eur Heart J. 2016.
    PubMed     Text format    


    October 2016
  88. ALFONSO F, Rivero F
    Coronary revascularization in diabetic patients with chronic kidney disease.
    Eur Heart J. 2016.
    PubMed     Text format    


    September 2016
  89. JORGE C, Hiltrop N, Desmet W
    Heart failure with preserved ejection fraction: blame the veins....
    Eur Heart J. 2016.
    PubMed     Text format    


  90. KOYAMA M, Yano T, Kikuchi K, Nagahara D, et al
    Lethal heart failure with anti-mitochondrial antibody: an arrhythmogenic right ventricular cardiomyopathy mimetic.
    Eur Heart J. 2016.
    PubMed     Text format    


    August 2016
  91. YAMAJI K, Raber L, Zanchin T, Spitzer E, et al
    Ten-year clinical outcomes of first-generation drug-eluting stents: the Sirolimus-Eluting vs. Paclitaxel-Eluting Stents for Coronary Revascularization (SIRTAX) VERY LATE trial.
    Eur Heart J. 2016.
    PubMed     Text format     Abstract available


  92. BABER U, Farkouh ME, Arbel Y, Muntner P, et al
    Comparative efficacy of coronary artery bypass surgery vs. percutaneous coronary intervention in patients with diabetes and multivessel coronary artery disease with or without chronic kidney disease.
    Eur Heart J. 2016.
    PubMed     Text format     Abstract available


  93. EISEN A, Cannon CP, Blazing MA, Bohula EA, et al
    The benefit of adding ezetimibe to statin therapy in patients with prior coronary artery bypass graft surgery and acute coronary syndrome in the IMPROVE-IT trial.
    Eur Heart J. 2016.
    PubMed     Text format     Abstract available


    June 2016
  94. HEIDBUCHEL H, Verhamme P, Alings M, Antz M, et al
    Updated European Heart Rhythm Association practical guide on the use of non-vitamin-K antagonist anticoagulants in patients with non-valvular atrial fibrillation: Executive summary.
    Eur Heart J. 2016.
    PubMed     Text format     Abstract available


    May 2016
  95. PONIKOWSKI P, Voors AA, Anker SD, Bueno H, et al
    2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contributio
    Eur Heart J. 2016.
    PubMed     Text format    


    April 2016
  96. MADONNA R, Van Laake LW, Davidson SM, Engel FB, et al
    Position Paper of the European Society of Cardiology Working Group Cellular Biology of the Heart: cell-based therapies for myocardial repair and regeneration in ischemic heart disease and heart failure.
    Eur Heart J. 2016.
    PubMed     Text format     Abstract available


    February 2016
  97. DIENER HC, Aisenberg J, Ansell J, Atar D, et al
    Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 1.
    Eur Heart J. 2016.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ischemic Heart Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: